Capped: A team-by-team buy-and-sell – Part 4

Alexander MacLean


With news that the NHL is making progress on returning, we move on to week four of our buy/sell series. Up next, we have some bubble teams that are hoping their offseason moves will turn out to be more effective than just shuffling the deck chairs on the Titanic. Let's get back to it with both New Yorks, New Jersey, and Nashville. The first three Capped buy-and-sell columns can be seen here.

To reiterate for the uninitiated, this multi-week feature will cover each NHL team, analyzing one player to buy and one to sell. These recommendations will be based on their performance versus cap hit. That means in non-cap leagues, some of these suggestions may not be as relevant, but that doesn't mean the analysis isn't relevant. Generally, these players will either be riding new contracts into the season or be expected to have a large shift in value, for one reason or another. We went alphabetically last year, so this time we're going for the reverse.



New York Rangers

Buy: Mika Zibanejad

Current Cap Hit: $5,350,000

Who do you think managers in your fantasy league will value more highly, Aleksander Barkov, Brad Marchand, J.T. Miller, Mark Scheifele, or Zibanejad. By my numbers, Zibanejad is the most valuable of the set, and earns less than all but Miller. Zibs was finally hitting his full stride, averaging four points every three games, and pacing for nearly 60 goals. He may be expensive to buy, but he's worth the cost because he can be one of the most valuable pieces in the fantasy game without the same name value that comes with the other players listed above.


Sell: Chris Kreider

Current Cap Hit: $6,500,000

Kreider was someone I was eyeing as an option for this space even before I remembered that his extension was a high $6.5 million AAV instead of something around $5 million that might have been more reasonable (do you think the Rangers want a do-over on that now with the flat cap?). Kreide